KOSDAQ · 089890 · Machinery · ₩089890

Koses코세스

089890 · KOSDAQ · ₩089890 · 코세스

₩36,250▲ ₩3,550 (10.86%)End-of-day · Oct 27, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결
Predicted impact: Low
Oct 27, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Aug 6, 2026Open on DART
Trading halt주권매매거래정지 (단일판매공급계약)Jul 13, 2026Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Jul 13, 2026Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jul 10, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
Amended attachment: Major sales or supply contract[첨부정정]단일판매ㆍ공급계약체결Apr 30, 2026Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Apr 20, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
Audit report submitted감사보고서제출Mar 23, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 9, 2026Open on DART
Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jan 28, 2026Open on DART
Treasury share sale decision주요사항보고서(자기주식처분결정)Jan 23, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Dec 22, 2025Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Dec 15, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 11, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 8, 2025Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Nov 28, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 28, 2025Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 24, 2025Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Sep 15, 2025Open on DART
Half-year report (Jun 2025)반기보고서 (2025.06)Aug 29, 2025Open on DART
Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Aug 11, 2025Open on DART
Quarterly report (Mar 2025)분기보고서 (2025.03)May 30, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 17, 2025Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Apr 3, 2025Open on DART
Annual general meeting results정기주주총회결과Mar 31, 2025Open on DART
Annual report (Dec 2024)사업보고서 (2024.12)Mar 21, 2025Open on DART
Audit report submitted감사보고서제출Mar 19, 2025Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Mar 17, 2025Open on DART
Shareholders' meeting called주주총회소집결의Mar 14, 2025Open on DART
Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 14, 2025Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 14, 2025Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 28, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 19, 2025Open on DART
Trust Contract Termination Result Report신탁계약해지결과보고서Feb 18, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 12, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 24, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 18, 2024Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 13, 2024Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 9, 2024Open on DART
Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 29, 2024Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Nov 15, 2024Open on DART
Status Report on Acquisition Under Trust Agreement신탁계약에의한취득상황보고서Nov 14, 2024Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 20, 2024Open on DART

Titles in Korean until English translations are added.

Also known as: Koses / 코세스 / 089890 / KRX:089890

Source: KRX statistical information